MedPath

Lipomed GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

EMA:7
CIMA_AEMPS:2
EMC:1

Drug Approvals

Thalidomide Lipomed

Authorization Status
Authorised
Approval Date
Sep 19, 2022
EMA

Thalidomide Lipomed

Authorization Status
Authorised
Approval Date
Sep 19, 2022
EMA

Jayempi

Authorization Status
Authorised
Approval Date
Jun 21, 2021
EMA

Xromi

Authorization Status
Authorised
Approval Date
Jul 1, 2019
EMA

Deferiprone Lipomed

Authorization Status
Authorised
Approval Date
Sep 19, 2018
EMA

Xaluprine (previously Mercaptopurine Nova Laboratories)

Authorization Status
Authorised
Approval Date
Mar 9, 2012
EMA

Litak

Authorization Status
Authorised
Approval Date
Apr 14, 2004
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.